<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1139-7632</journal-id>
<journal-title><![CDATA[Pediatría Atención Primaria]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Pediatr Aten Primaria]]></abbrev-journal-title>
<issn>1139-7632</issn>
<publisher>
<publisher-name><![CDATA[Asociación Española de Pediatría de Atención Primaria]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1139-76322019000200005</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Tratamiento hospitalario de la bronquiolitis moderada-grave: ¿suero salino hipertónico o fisiológico? Análisis de factores de riesgo asociados al reingreso]]></article-title>
<article-title xml:lang="en"><![CDATA[Hospital treatment of moderate-severe bronchiolitis, hypertonic or physiological saline? Analysis of risk factors associated with readmission]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferrer Vázquez]]></surname>
<given-names><![CDATA[Mario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Álvarez Martín]]></surname>
<given-names><![CDATA[Marta]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Delgado Vicente]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Álvarez Chamorro]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tosca Segura]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General Universitario de Castellón Unidad de Neumología y Alergia Pediátricas ]]></institution>
<addr-line><![CDATA[Castellón de la Plana ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<volume>21</volume>
<numero>82</numero>
<fpage>e31</fpage>
<lpage>e40</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1139-76322019000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1139-76322019000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1139-76322019000200005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[ Introducción A pesar de los numerosos estudios publicados hasta la fecha sobre el tratamiento hospitalario de la bronquiolitis y de la prometedora eficacia del suero salino hipertónico, lo cierto es que existe controversia al respecto.  Material y métodos Estudio observacional prospectivo que evalúa la eficacia del suero salino hipertónico al 3% frente al suero fisiológico en el tratamiento hospitalario de la bronquiolitis, en términos de reducción de estancia y de puntuación de escala clínica de gravedad; en una segunda fase se analizan factores de riesgo asociados al reingreso por broncoespasmo de los mismos pacientes.  Resultados Se analizan 67 de los 73 pacientes ingresados por bronquiolitis, de los cuales 9 recibieron fisiológico y 58 hipertónico, con o sin broncodilatador asociado. La estancia hospitalaria fue de 6,07 ± 3,12 días para el grupo fisiológico, y de 6,67 ± 4,36 días para el grupo con hipertónico. La media de la puntuación (Wood-Downes modificado por Ferrés) para el grupo con fisiológico fue de 3,67 ± 1,1 y de 3,16 ± 1,1 para los que recibieron hipertónico. Para la segunda fase se obtiene una tasa de reingresos del 8,2%.  Conclusiones No encontramos diferencias significativas entre ambos grupos en tiempo de hospitalización ni en mejoría de escala clínica y días de oxigenoterapia. Pese al reducido tamaño muestral no observamos ninguna tendencia a favor de diferencias significativas en nuestra muestra. Los factores más relacionados con el reingreso han sido la edad menor a 6 meses, el sexo masculino, el tener hermanos mayores y el tabaquismo familiar.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ Introduction Although numerous studies have been published to date on the subject of inpatient management of bronchiolitis and the promising outcomes obtained with hypertonic saline, this subject remains controversial.  Materials and methods We conducted a prospective observational study to assess the effectiveness of 3% hypertonic saline compared to physiological saline in the inpatient management of bronchiolitis, understood as the achieved reductions in length of stay and clinical severity scores. In a second phase, we analysed the risk factors associated with readmission due to bronchospasm in the same sample of patients.  Results We included 67 out of the 73 patients admitted with bronchiolitis in the analysis, of who 9 received physiological saline and 58 hypertonic saline, with or without an added bronchodilator. The mean length of stay was 6.07 ± 3.12 days in the physiological saline group and 6.67 ± 4.36 days in the hypertonic saline group. The mean severity score (Wood-Downes scale modified by Ferrés) was 3.67 ± 1.1 in the physiological saline group versus 3.16 ± 1.1 in the hypertonic saline group. In the second phase of the study, we found a readmission rate of 8.2%.  Conclusion We did not find statistically significant differences between the two groups in the length of stay or in the improvement in the clinical severity score or duration of oxygen therapy. Although the sample size was small, we did not find any trends in our sample suggesting the actual presence of significant differences. The factors associated most strongly with readmission were age of less than 6 months, male sex, having older siblings and exposure to smoke in the household.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Pediatría]]></kwd>
<kwd lng="es"><![CDATA[Bronquiolitis]]></kwd>
<kwd lng="es"><![CDATA[Broncoespasmo]]></kwd>
<kwd lng="es"><![CDATA[Nebulizadores]]></kwd>
<kwd lng="es"><![CDATA[Solución salina hipertónica]]></kwd>
<kwd lng="en"><![CDATA[Paediatrics]]></kwd>
<kwd lng="en"><![CDATA[Bronchiolitis]]></kwd>
<kwd lng="en"><![CDATA[Bronchospasm]]></kwd>
<kwd lng="en"><![CDATA[Nebulizers]]></kwd>
<kwd lng="en"><![CDATA[Hypertonic saline solution]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calvo Rey]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Garci&#769;a Garci&#769;a]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Casas Flecha]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Pe&#769;rez Bren&#771;a]]></surname>
<given-names><![CDATA[IP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infecciones respiratorias virales]]></article-title>
<source><![CDATA[Asociación Española de Pediatría]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<collab>American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis</collab>
<article-title xml:lang=""><![CDATA[Diagnosis and management of bronchiolitis]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2006</year>
<volume>118</volume>
<page-range>1774-93</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochoa Sangrador]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[González de Dios]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<collab>Grupo de Revisión del Proyecto aBREVIADo</collab>
<article-title xml:lang=""><![CDATA[Conferencia de consenso sobre bronquiolitis aguda (II): epidemiología de la bronquiolitis aguda. Revisión de la evidencia científica]]></article-title>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2010</year>
<volume>72</volume>
<page-range>222.e1-222.e26</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramos-Fernández]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Pedrero-Segura]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez-Bedmar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado-Martín]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cordón-Martínez]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Pérez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de los ingresos por bronquiolitis en el sur de Europa]]></article-title>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2017</year>
<volume>87</volume>
<page-range>260-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González de Dios]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa Sangrador]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<collab>Grupo de Revisión del Proyecto aBREVIADo</collab>
<article-title xml:lang=""><![CDATA[Conferencia de consenso sobre bronquiolitis aguda (I): metodología y recomendaciones]]></article-title>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2010</year>
<volume>72</volume>
<page-range>221.e1-221.e33</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sigurs]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gustafsson]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Bjarnason]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lundberg]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sigurbergsson]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2005</year>
<volume>171</volume>
<page-range>137-41</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Sherrill]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Morgan]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Holberg]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Halonen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Taussig]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1999</year>
<volume>354</volume>
<page-range>541-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González de Dios]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa Sangrador]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<collab>Grupo de Revisión de Proyecto aBREVIADo</collab>
<article-title xml:lang=""><![CDATA[Conferencia de Consenso sobre bronquiolitis aguda (IV): tratamiento de la bronquiolitis aguda]]></article-title>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2010</year>
<volume>72</volume>
<page-range>285.e1-285.e42</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ipek]]></surname>
<given-names><![CDATA[IO]]></given-names>
</name>
<name>
<surname><![CDATA[Yalcin]]></surname>
<given-names><![CDATA[EU]]></given-names>
</name>
<name>
<surname><![CDATA[Sezer]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Bozaykut]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in moderate bronchiolitis]]></article-title>
<source><![CDATA[Pulm Pharmacol Ther]]></source>
<year>2011</year>
<volume>24</volume>
<page-range>633-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hartling]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Bialy]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Milne]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Klassen]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2011</year>
<volume>342</volume>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochoa Sangrador]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gonza&#769;lez de Dios]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Broncodilatadores y corticoides en la bronquiolitis aguda: adrenalina nebulizada y poco ma&#769;s]]></article-title>
<source><![CDATA[Evid Pediatr]]></source>
<year>2011</year>
<volume>7</volume>
<page-range>42</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Sassi]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Klassen]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[Wainwright]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nebulized hypertonic saline for acute bronchiolitis: a systematic review]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2015</year>
<volume>136</volume>
<page-range>687-701</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Florin]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Shaw]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
<name>
<surname><![CDATA[Kittick]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial]]></article-title>
<source><![CDATA[JAMA Pediatr]]></source>
<year>2014</year>
<volume>168</volume>
<page-range>664-70</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial]]></article-title>
<source><![CDATA[JAMA Pediatr]]></source>
<year>2014</year>
<volume>168</volume>
<page-range>657-63</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer-Vázquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Suero salino hipertónico en el tratamiento de la bronquiolitis. ¿La nebulización ideal o una más?]]></article-title>
<source><![CDATA[Bol Soc Val Pediatr]]></source>
<year>2014</year>
<volume>34</volume>
<page-range>41</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez Carrasco]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El asma en los primeros años de la vida y su relación con las infecciones virales]]></article-title>
<source><![CDATA[Rev Pediatr Aten Primaria]]></source>
<year>2006</year>
<volume>8</volume>
<page-range>453-75</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Fernández]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características epidemiológicas del lactante con primer episodio sibilante: ¿podemos identificar al niño con riesgo de episodio grave o de recidiva?]]></article-title>
<source><![CDATA[Rev Esp Pediatr]]></source>
<year>2008</year>
<volume>64</volume>
<page-range>447-51</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez Rodríguez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Otheo de Tejada Barasoain]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ros Pérez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bronquiolitis en Pediatría: puesta al día]]></article-title>
<source><![CDATA[Inf Ter Sist Nac Salud]]></source>
<year>2010</year>
<volume>34</volume>
<page-range>3-11</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Saai]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Wainwright]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Klassen]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nebulized hypertonic saline for acute bronchiolitis: a systematic review]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2015</year>
<volume>136</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>687-701</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ralston]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Lieberthal]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Meissner]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Alverson]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Baley]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Gadomski]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<collab>American Academy of Pediatrics</collab>
<article-title xml:lang=""><![CDATA[Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2014</year>
<volume>134</volume>
<page-range>e1474-502</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuentes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cornejo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bustos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización en el tratamiento de bronquiolitis aguda: menos es más]]></article-title>
<source><![CDATA[Neumol Pediatr]]></source>
<year>2016</year>
<volume>11</volume>
<page-range>65-70</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<collab>National Collaborating Centre for Women&#8217;s and Children's Health (UK)</collab>
<source><![CDATA[Bronchiolitis: Diagnosis and Management of Bronchiolitis in Children]]></source>
<year></year>
<publisher-name><![CDATA[National Institute for Health and Care Excellence]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Friedman]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Rieder]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Walton]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<collab>Canadian Paediatric Society</collab>
<collab>Acute Care Committee</collab>
<collab>Drug Therapy and Hazardous Substances Committee</collab>
<article-title xml:lang=""><![CDATA[Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age]]></article-title>
<source><![CDATA[Paediatr Child Health]]></source>
<year>2014</year>
<volume>19</volume>
<page-range>485-98</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pe&#769;rez Cid]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[San Jose&#769; Valiente]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Quintero Calcan&#771;o]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Di&#769;az Lo&#769;pez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mesa Guzma&#769;n]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Can&#771;ete Di&#769;az]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La bronquiolitis grave en lactantes menores de seis meses es un factor de riesgo para las sibilancias recurrentes]]></article-title>
<source><![CDATA[Rev Pediatr Aten Primaria]]></source>
<year>2013</year>
<volume>15</volume>
<page-range>229-37</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
